SEC Form 4 · accession 0001127602-19-009916
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald W Penczek
Officer — SVP, Chief Accounting Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | F | 512 | $307.68 | D | 416 | D | |
| Common StockF2 | Mar 1, 2019 | A | 1,217 | $0.00 | A | 1,633 | D | |
| Common StockF3 | Mar 1, 2019 | A | 305 | $0.00 | A | 1,938 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $307.68 | Mar 1, 2019 | A | 1,403 | A | — | Mar 1, 2029 | Common Stock | 1,403 | 1,403 | D |
Explanation of responses
- F1PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- F2Represents performance based restricted share units. Restrictions lapse on 3/1/19.
- F3Represents restricted share units. Restrictions lapse as follows: 101 shares on 3/1/2020, and 102 shares each on 3/1/2021 and 3/1/2022.
- F4The option represents a right to purchase a total of 1,403 shares, and is exercisable in three annual installments, with one installment of 467 shares and two installments of 468 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date.